Type 3 Diabetes – A New Condition and What It Means To You

Type 3 diabetes is a newly discovered disease associated with some very
serious consequences. The disease was first recognized in 2005 when
scientists discovered that insulin, previously thought to only be
produced in the pancreas, was also produced within the brain.

Much is still being learned about this disorder but it is being
looked at with much interest because of its apparent link to
degeneration of brain cells, which is an early symptom of Alzheimer’s
Disease (AD).

Unlike type 1 and type 2 diabetes, which result due to
errors in the production of insulin from the pancreas or an issue with
resistance to insulin, diabetes type 3 appears to be a more complex
disease that originated in the brain.

The brain requires insulin for the survival of its
cells. In this type of diabetes, the brain is not able to secrete enough
insulin and this leads to brain cell deterioration.

The connection between type 3 diabetes and Alzheimer’s
is not fully understood but researchers believe that patients with
Alzheimer’s have a protein in their brain that removes insulin receptors
from the brain’s cells. This prevents the brain cells from receiving
the required insulin and the cells die.

Since its discovery, many theories have developed as to
what might cause this disease. One theory is that type 3 diabetes
affects people who are overly sensitive to electrical energy and
connects the disease to the increased use of electronic devices of the
modern age.

This "electropollution" is thought to be generated from
items such as computers, televisions, wireless phones and even certain
fluorescent light bulbs. Though some research has been done and does
show an interesting correlation between electromagnetic fields and
diabetes, the true cause of type 3 diabetes has yet to be determined.

Type 3 diabetes is still new and much more research is
needed before widespread diagnostic tests and treatments can be made
available. However, its discover is thought by some scientists to be a
major step forward in the fight against Alzheimer’s Disease (AD) and
dementia disorders.

Researchers now believe that, "Understanding the connection between
insulin function and AD might enable discovery of a drug-combination
that prevents, delays, or halts progression of sporadic AD" (1).